{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:32:55Z","timestamp":1787506375257,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82371305"],"award-info":[{"award-number":["No. 82371305"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Moyamoya disease (MMD) is a significant cause of childhood stroke and transient ischemic attacks (TIAs). This study aimed to assess the safety and efficacy of remote ischemic conditioning (RIC) in children with MMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a single-center pilot study, 46 MMD patients aged 4 to 14\u00a0years, with no history of reconstructive surgery, were randomly assigned to receive either RIC or sham RIC treatment twice daily for a year. The primary outcome measured was the cumulative incidence of major adverse cerebrovascular events (MACEs). Secondary outcomes included ischemic stroke, recurrent TIA, hemorrhagic stroke, revascularization rates, and clinical improvement assessed using the patient global impression of change (PGIC) scale during follow-up. RIC-related adverse events were also recorded, and cerebral hemodynamics were evaluated using transcranial Doppler.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All 46 patients completed the final follow-up (23 each in the RIC and sham RIC groups). No severe adverse events associated with RIC were observed. Kaplan\u2013Meier analysis indicated a significant reduction in MACEs frequency after RIC treatment [log-rank test (Mantel\u2013Cox),\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.021]. At 3-year follow-up, two (4.35%) patients had an ischemic stroke, four (8.70%) experienced TIAs, and two (4.35%) underwent revascularization as the qualifying MACEs. The clinical improvement rate in the RIC group was higher than the sham RIC group on the PGIC scale (65.2% vs. 26.1%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). No statistical difference in cerebral hemodynamics post-treatment was observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>RIC is a safe and effective adjunct therapy for asymptomatic children with MMD. This was largely due to the reduced incidence of ischemic cerebrovascular events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s12519-024-00824-z","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T14:02:57Z","timestamp":1719842577000},"page":"925-934","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Remote ischemic conditioning prevents ischemic cerebrovascular events in children with moyamoya disease: a randomized controlled trial"],"prefix":"10.1007","volume":"20","author":[{"given":"Shuang-Feng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Qin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun-Ming","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8329-1186","authenticated-orcid":false,"given":"Si-Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"824_CR1","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226\u201337.","journal-title":"N Engl J Med"},{"key":"824_CR2","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/jnnp.2007.130666","volume":"79","author":"T Baba","year":"2008","unstructured":"Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79:900\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"824_CR3","first-page":"100331","volume":"18","author":"D Zhang","year":"2022","unstructured":"Zhang D, Huang L, Huang Z, Zhou Q, Yang X, Gu H, et al. Epidemiology of moyamoya disease in China: a nationwide hospital-based study. Lancet Reg Health West Pac. 2022;18:100331.","journal-title":"Lancet Reg Health West Pac"},{"key":"824_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10143-018-0994-5","volume":"43","author":"S Shang","year":"2020","unstructured":"Shang S, Zhou D, Ya J, Li S, Yang Q, Ding Y, et al. Progress in moyamoya disease. Neurosurg Rev. 2020;43:371\u201382.","journal-title":"Neurosurg Rev"},{"key":"824_CR5","first-page":"1276","volume":"14","author":"TY You","year":"2023","unstructured":"You TY, Dong Q, Cui M. Emerging links between cerebral blood flow regulation and cognitive decline: a role for brain microvascular pericytes. Aging Dis. 2023;14:1276\u201391.","journal-title":"Aging Dis"},{"key":"824_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.7150\/ijms.11719","volume":"12","author":"J Piao","year":"2015","unstructured":"Piao J, Wu W, Yang Z, Yu J. Research progress of moyamoya disease in children. Int J Med Sci. 2015;12:566\u201375.","journal-title":"Int J Med Sci"},{"key":"824_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2176\/jns-nmc.2022-0072","volume":"62","author":"S Kuroda","year":"2022","unstructured":"Kuroda S, Fujimura M, Takahashi J, Kataoka H, Ogasawara K, Iwama T, et al. Diagnostic criteria for moyamoya disease\u20142021 revised version. Neurol Med Chir (Tokyo). 2022;62:307\u201312.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"824_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/bc.bc_20_22","volume":"8","author":"D Hazra","year":"2022","unstructured":"Hazra D, Chandy GM, Ghosh AK. A single-center retrospective observational study on patients undergoing encephalo-duro-arterio-myo-synangiosis in patients with moyamoya disease. Brain Circ. 2022;8:94\u2013101.","journal-title":"Brain Circ"},{"key":"824_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4103\/bc.bc_52_22","volume":"8","author":"F Eren","year":"2022","unstructured":"Eren F, Yilmaz SE. Neuroprotective approach in acute ischemic stroke: a systematic review of clinical and experimental studies. Brain Circ. 2022;8:172\u20139.","journal-title":"Brain Circ"},{"key":"824_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12975-017-0555-1","volume":"9","author":"MB Khan","year":"2018","unstructured":"Khan MB, Hafez S, Hoda MN, Baban B, Wagner J, Awad ME, et al. Chronic remote ischemic conditioning is cerebroprotective and induces vascular remodeling in a VCID model. Transl Stroke Res. 2018;9:51\u201363.","journal-title":"Transl Stroke Res"},{"key":"824_CR11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.14336\/AD.2017.1106","volume":"9","author":"C Ren","year":"2018","unstructured":"Ren C, Li N, Li S, Han R, Huang Q, Hu J, et al. Limb ischemic conditioning improved cognitive deficits via eNOS-dependent augmentation of angiogenesis after chronic cerebral hypoperfusion in rats. Aging Dis. 2018;9:869\u201379.","journal-title":"Aging Dis"},{"key":"824_CR12","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/STROKEAHA.107.499079","volume":"39","author":"JY Wang","year":"2008","unstructured":"Wang JY, Shen J, Gao Q, Ye ZG, Yang SY, Liang HW, et al. Ischemic postconditioning protects against global cerebral ischemia\/reperfusion-induced injury in rats. Stroke. 2008;39:983\u201390.","journal-title":"Stroke"},{"key":"824_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/cns.13279","volume":"26","author":"JY Ding","year":"2020","unstructured":"Ding JY, Shang SL, Sun ZS, Asmaro K, Li WL, Yang Q, et al. Remote ischemic conditioning for the treatment of ischemic moyamoya disease. CNS Neurosci Ther. 2020;26:549\u201357.","journal-title":"CNS Neurosci Ther"},{"key":"824_CR14","doi-asserted-by":"publisher","first-page":"811854","DOI":"10.3389\/fneur.2021.811854","volume":"12","author":"J Xu","year":"2021","unstructured":"Xu J, Zhang Q, Rajah GB, Zhao W, Wu F, Ding Y, et al. Daily remote ischemic conditioning can improve cerebral perfusion and slow arterial progression of adult moyamoya disease-a randomized controlled study. Front Neurol. 2021;12:811854.","journal-title":"Front Neurol"},{"key":"824_CR15","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3174\/ajnr.A3819","volume":"35","author":"DK Jang","year":"2014","unstructured":"Jang DK, Lee KS, Rha HK, Huh PW, Yang JH, Park IS, et al. Clinical and angiographic features and stroke types in adult moyamoya disease. AJNR Am J Neuroradiol. 2014;35:1124\u201331.","journal-title":"AJNR Am J Neuroradiol"},{"key":"824_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/bc.bc_30_17","volume":"3","author":"S Li","year":"2017","unstructured":"Li S, Zhao W, Han C, Rajah GB, Ren C, Xu J, et al. Safety and efficacy of remote ischemic conditioning in pediatric moyamoya disease patients treated with revascularization therapy. Brain Circ. 2017;3:213\u20138.","journal-title":"Brain Circ"},{"key":"824_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","volume":"52","author":"On the Pathology, Research Committee and others","year":"2012","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases.\u00a0Guidelines for diagnosis and treatment of moyamoya disease spontaneous occlusion of the circle of Willis. Neurol Med Chir (Tokyo). 2012;52:245\u201366.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"824_CR18","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1161\/STROKEAHA.122.041932","volume":"54","author":"S Kuroda","year":"2023","unstructured":"Kuroda S, Yamamoto S, Funaki T, Fujimura M, Kataoka H, Hishikawa T, et al. Five-year stroke risk and its predictors in asymptomatic moyamoya disease: Asymptomatic Moyamoya Registry (AMORE). Stroke. 2023;54:1494\u2013504.","journal-title":"Stroke"},{"key":"824_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12883-020-01898-8","volume":"20","author":"S He","year":"2020","unstructured":"He S, Duan R, Liu Z, Ye X, Yuan L, Li T, et al. Characteristics of cognitive impairment in adult asymptomatic moyamoya disease. BMC Neurol. 2020;20:322.","journal-title":"BMC Neurol"},{"key":"824_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","volume":"62","author":"M Fujimura","year":"2022","unstructured":"Fujimura M, Tominaga T, Kuroda S, Takahashi JC, Endo H, Ogasawara K, et al. 2021 Japanese guidelines for the management of moyamoya disease: guidelines from the research committee on moyamoya disease and Japan stroke society. Neurol Med Chir (Tokyo). 2022;62:165\u201370.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"824_CR21","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1152\/physrev.00009.2003","volume":"83","author":"DM Yellon","year":"2003","unstructured":"Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev. 2003;83:1113\u201351.","journal-title":"Physiol Rev"},{"key":"824_CR22","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1161\/STROKEAHA.108.189696","volume":"39","author":"ES Roach","year":"2008","unstructured":"Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, et al. Management of stroke in infants and children: a scientific statement from a special writing group of the American heart association stroke council and the council on cardiovascular disease in the young. Stroke. 2008;39:2644\u201391.","journal-title":"Stroke"},{"key":"824_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pediatrneurol.2023.12.002","volume":"151","author":"LR Sun","year":"2024","unstructured":"Sun LR, Gatti JR, Ahmad SA, Burton N, Ziai W, Gottesman RF, et al. Transcranial Doppler in childhood moyamoya: an underutilized tool? Pediatr Neurol. 2024;151:111\u20134.","journal-title":"Pediatr Neurol"},{"key":"824_CR24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/adc.63.6.606","volume":"63","author":"H Bode","year":"1988","unstructured":"Bode H, Wais U. Age dependence of flow velocities in basal cerebral arteries. Arch Dis Child. 1988;63:606\u201311.","journal-title":"Arch Dis Child"},{"key":"824_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/nur.20247","volume":"31","author":"MA Hertzog","year":"2008","unstructured":"Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31:180\u201391.","journal-title":"Res Nurs Health"},{"key":"824_CR26","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1161\/STR.0000000000000183","volume":"50","author":"DM Ferriero","year":"2019","unstructured":"Ferriero DM, Fullerton HJ, Bernard TJ, Billinghurst L, Daniels SR, DeBaun MR, et al. Management of stroke in neonates and children: a scientific statement from the American Heart Association\/American Stroke Association. Stroke. 2019;50:e51\u201396.","journal-title":"Stroke"},{"key":"824_CR27","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/STROKEAHA.113.004526","volume":"45","author":"MM Adil","year":"2014","unstructured":"Adil MM, Qureshi AI, Beslow LA, Jordan LC. Transient ischemic attack requiring hospitalization of children in the United States: kids\u2019 inpatient database 2003 to 2009. Stroke. 2014;45:887\u20138.","journal-title":"Stroke"},{"key":"824_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1161\/STROKEAHA.115.011173","volume":"47","author":"HJ Fullerton","year":"2016","unstructured":"Fullerton HJ, Wintermark M, Hills NK, Dowling MM, Tan M, Rafay MF, et al. Risk of recurrent arterial ischemic stroke in childhood: a prospective international study. Stroke. 2016;47:53\u20139.","journal-title":"Stroke"},{"key":"824_CR29","doi-asserted-by":"publisher","first-page":"892445","DOI":"10.3389\/fped.2022.892445","volume":"10","author":"C Po","year":"2022","unstructured":"Po C, Nosadini M, Zedde M, Pascarella R, Mirone G, Cicala D, et al. Pediatric moyamoya disease and syndrome in Italy: a multicenter cohort. Front Pediatr. 2022;10:892445.","journal-title":"Front Pediatr"},{"key":"824_CR30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ana.21981","volume":"68","author":"SK Kim","year":"2010","unstructured":"Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, et al. Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol. 2010;68:92\u2013101.","journal-title":"Ann Neurol"},{"key":"824_CR31","first-page":"846830","volume":"2014","author":"P Zhang","year":"2014","unstructured":"Zhang P, Xu Q, Dai J, Wang J, Zhang N, Luo Y. Dysfunction of affective network in post ischemic stroke depression: a resting-state functional magnetic resonance imaging study. Biomed Res Int. 2014;2014:846830.","journal-title":"Biomed Res Int"},{"key":"824_CR32","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/2011.10.FOCUS11228","volume":"31","author":"N Lin","year":"2011","unstructured":"Lin N, Baird L, Koss M, Kopecky KE, Gone E, Ullrich NJ, et al. Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression. Neurosurg Focus. 2011;31:E6.","journal-title":"Neurosurg Focus"},{"key":"824_CR33","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1161\/STROKEAHA.122.038771","volume":"53","author":"JR Gatti","year":"2022","unstructured":"Gatti JR, Sun LR. Nonischemic presentations of pediatric moyamoya arteriopathy: a natural history study. Stroke. 2022;53:e219\u201320.","journal-title":"Stroke"},{"key":"824_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/23969873221144089","volume":"8","author":"A Bersano","year":"2023","unstructured":"Bersano A, Khan N, Fuentes B, Acerbi F, Canavero I, Tournier-Lasserve E, et al. European stroke organisation (ESO) guidelines on moyamoya angiopathy endorsed by Vascular European Reference Network (VASCERN). Eur Stroke J. 2023;8:55\u201384.","journal-title":"Eur Stroke J"},{"key":"824_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/acn3.691","volume":"6","author":"W Zhao","year":"2019","unstructured":"Zhao W, Li S, Ren C, Meng R, Jin K, Ji X. Remote ischemic conditioning for stroke: clinical data, challenges, and future directions. Ann Clin Transl Neurol. 2019;6:186\u201396.","journal-title":"Ann Clin Transl Neurol"},{"key":"824_CR36","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/jama.2022.13123","volume":"328","author":"HS Chen","year":"2022","unstructured":"Chen HS, Cui Y, Li XQ, Wang XH, Ma YT, Zhao Y, et al. Effect of remote ischemic conditioning vs usual care on neurologic function in patients with acute moderate ischemic stroke: the RICAMIS randomized clinical trial. JAMA. 2022;328:627\u201336.","journal-title":"JAMA"},{"key":"824_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12975-015-0437-3","volume":"7","author":"AN Laiwalla","year":"2016","unstructured":"Laiwalla AN, Ooi YC, Liou R, Gonzalez NR. Matched cohort analysis of the effects of limb remote ischemic conditioning in patients with aneurysmal subarachnoid hemorrhage. Transl Stroke Res. 2016;7:42\u20138.","journal-title":"Transl Stroke Res"},{"key":"824_CR38","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S1474-4422(22)00335-0","volume":"21","author":"C Hou","year":"2022","unstructured":"Hou C, Lan J, Lin Y, Song H, Wang Y, Zhao W, et al. Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in China. Lancet Neurol. 2022;21:1089\u201398.","journal-title":"Lancet Neurol"},{"key":"824_CR39","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1161\/STROKEAHA.117.017691","volume":"48","author":"Y Wang","year":"2017","unstructured":"Wang Y, Meng R, Song H, Liu G, Hua Y, Cui D, et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small-vessel disease. Stroke. 2017;48:3064\u201372.","journal-title":"Stroke"},{"key":"824_CR40","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/cns.13874","volume":"28","author":"S Li","year":"2022","unstructured":"Li S, Zhao W, Liu G, Ren C, Meng R, Wang Y, et al. Chronic remote ischemic conditioning for symptomatic internal carotid or middle cerebral artery occlusion: a prospective cohort study. CNS Neurosci Ther. 2022;28:1365\u201371.","journal-title":"CNS Neurosci Ther"},{"key":"824_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/cns.12448","volume":"22","author":"ZJ Liu","year":"2016","unstructured":"Liu ZJ, Chen C, Li XR, Ran YY, Xu T, Zhang Y, et al. Remote ischemic preconditioning-mediated neuroprotection against stroke is associated with significant alterations in peripheral immune responses. CNS Neurosci Ther. 2016;22:43\u201352.","journal-title":"CNS Neurosci Ther"},{"key":"824_CR42","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2147\/NDT.S231944","volume":"16","author":"C Qin","year":"2020","unstructured":"Qin C, Yan X, Jin H, Zhang R, He Y, Sun X, et al. Effects of remote ischemic conditioning on cerebral hemodynamics in ischemic stroke. Neuropsychiatr Dis Treat. 2020;16:283\u201399.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"824_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4103\/bc.bc_57_22","volume":"9","author":"Y Xu","year":"2023","unstructured":"Xu Y, Wang Y, Ji X. Immune and inflammatory mechanism of remote ischemic conditioning: a narrative review. Brain Circ. 2023;9:77\u201387.","journal-title":"Brain Circ"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-024-00824-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-024-00824-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-024-00824-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T23:53:44Z","timestamp":1727222024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-024-00824-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["824"],"URL":"https:\/\/doi.org\/10.1007\/s12519-024-00824-z","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]},"assertion":[{"value":"12 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was registered at\n                      \n                      (unique identifier: NCT03821181), approved by the Ethics Committee of Xuanwu Hospital of Capital Medical University (2019012), and conducted according to the ethical guidelines of the Declaration of Helsinki. All participants or their legally authorized representatives provided informed consent before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. The authors have no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}